Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 172,560 | 206,180 | 115,412 | 64,330 | 8,993 |
| Marketable Securities | 351,721 | 417,770 | 439,396 | 296,112 | 63,119 |
| Receivables | 3,255 | 5,897 | 1,012 | 0 | N/A |
| TOTAL | $542,751 | $637,949 | $563,159 | $367,128 | $73,966 |
| Non-Current Assets | |||||
| PPE Net | 18,644 | 22,505 | 18,778 | 7,224 | 3,984 |
| Other Non-Current Assets | 85,997 | 92,234 | 97,286 | 9,772 | 463 |
| TOTAL | $104,641 | $114,739 | $116,064 | $16,996 | $4,447 |
| Total Assets | $647,392 | $752,688 | $679,223 | $384,124 | $78,413 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,520 | 6,636 | 2,424 | 7,077 | 36 |
| Accrued Expenses | 24,342 | 20,178 | 20,767 | 12,992 | 7,189 |
| TOTAL | $42,909 | $37,006 | $35,095 | $22,024 | $7,315 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,605 | N/A | N/A | N/A | 90 |
| Other Non-Current Liabilities | 60,818 | 67,624 | 73,182 | 4,748 | 134,882 |
| TOTAL | $111,083 | $116,180 | $93,196 | $4,748 | $135,007 |
| Total Liabilities | $153,992 | $153,186 | $128,291 | $26,772 | $142,322 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,796 | 83,619 | 61,833 | 48,577 | N/A |
| Common Shares | 89 | 82 | 62 | 49 | 3 |
| Retained earnings | -743,014 | -544,305 | -344,237 | -186,850 | -66,536 |
| Other shareholders' equity | 428 | 272 | -694 | -228 | 8 |
| TOTAL | $493,400 | $599,502 | $550,932 | $357,352 | $-63,909 |
| Total Liabilities And Equity | $647,392 | $752,688 | $679,223 | $384,124 | $78,413 |